MicroRNA‑124 negatively regulates chloride intracellular channel 1 to suppress the migration and invasion of liver cancer cells
- Xupeng Yue
- Yuanyuan Cui
- Qi You
- Yanxin Lu
- Jufeng Zhang
Affiliations: Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, Guangdong 519041, P.R. China, The Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, WA 99163, USA, Medical and Nurse College, Sanmenxia Polytechnic, Sanmenxia, Henan 472000, P.R. China, School of Life Science, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China
- Published online on: July 25, 2019 https://doi.org/10.3892/or.2019.7250
Copyright: © Yue
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
The dysregulation of microRNAs (miRNAs) is associated with the development and progression of a variety of cancers, including liver cancer. Aberrant expression of miRNA (miR)‑124 has been demonstrated in liver cancer, but its functional mechanism in liver cancer is still largely unknown. Metastasis of liver cancer is one of the most common causes of mortality. The present study showed that miR‑124 inhibited the proliferation, migration and invasion of liver cancer cells. Furthermore, chloride intracellular channel 1 (CLIC1) was identified as a novel target of miR‑124 in liver cancer cells. Overexpression of miR‑124 reduced CLIC1 expression at both the protein and mRNA levels in liver cancer cells. Downregulation of CLIC1 decreased the migration and invasion of liver cancer cells without affecting cell proliferation. Taken together, these results showed that CLIC1 is a critical target for miR‑124‑mediated inhibitory effects on cell migration and invasion. Thus, miR‑124 or suppression of CLIC1 may have diagnostic value and therapeutic potential for the treatment of human liver cancer.